Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
BMC Cancer|March 6, 2014
Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patientsChann Lagadec, Erina Vlashi, Sunita Bhuta, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistanceVictoria Y Yu, Dan Nguyen, Frank Pajonk, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2025
Combined quetiapine and radiation therapy approach to treat mesothelioma-initiating cells and increase survival in a mouse model of mesotheliomaAnjelica Cardenas, Evelyn Arambula, Linda Azizi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2016
Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus StatusErina Vlashi, Allen M Chen, Sabrina Boyrie, et al.
Breast Cancer Research and Treatment|July 11, 2014
Metabolic differences in breast cancer stem cells and differentiated progenyErina Vlashi, Chann Lagadec, Laurent Vergnes, et al.
Neoplasia (New York, N.Y.)|December 31, 2020
Tumor necrosis factor receptor signaling modulates carcinogenesis in a mouse model of breast cancerLing He, Kruttika Bhat, Sara Duhacheck-Muggy, et al.
Translational Oncology|February 19, 2010
Differential Effects of the Proteasome Inhibitor NPI-0052 against Glioma CellsErina Vlashi, Malcom Mattes, Chann Lagadec, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Radiation-Induced Cellular Plasticity: A Strategy for Combatting GlioblastomaLing He, Daria Azizad, Kruttika Bhat, et al.
Antioxidants & Redox Signaling|July 20, 2023
Nicotinamide Adenine Dinucleotide Phosphate Oxidase Promotes Glioblastoma Radiation Resistance in a Phosphate and Tensin Homolog-Dependent MannerKirsten Ludwig, Janel E Le Belle, Sree Deepthi Muthukrishnan, et al.
Cancer Research Communications|June 5, 2024
Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1Ling He, Angeliki Ioannidis, Carter J Hoffman, et al.
Pageof 7